Genetically engineered vaccines.

about

The Role of Lipids in Development of Allergic Responses.

P2860

Q39416443-51F11672-02EB-4C05-889A-ACB1FB2C4954

P2860

Genetically engineered vaccines.

Item

http://www.wikidata.org/entity/Q36103226

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Genetically engineered vaccines.

@ast

Genetically engineered vaccines.

@en

type

Item

label

Genetically engineered vaccines.

@ast

Genetically engineered vaccines.

@en

prefLabel

Genetically engineered vaccines.

@ast

Genetically engineered vaccines.

@en

P1476

Genetically engineered vaccines.

@en

P2093

Belinda J Hales

http://www.w3.org/2001/XMLSchema#string

Wayne R Thomas

http://www.w3.org/2001/XMLSchema#string

Wendy-Anne Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1

Crystal structure of an antibody bound to an immunodominant peptide epitope: novel features in peptide-antibody recognition

Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis

C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and exclusive Th1 cell differentiation.

Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.

Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s.

Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model.

Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses.

Construction of hevein (Hev b 6.02) with reduced allergenicity for immunotherapy of latex allergy by comutation of six amino acid residues on the conformational IgE epitopes.

P2888

s11882-005-0038-4

P304

197-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11882-005-0038-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15842957

http://www.w3.org/2001/XMLSchema#string

Genetically engineered vaccines.

about

P2860

P2860

Genetically engineered vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698